0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Helex, a therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, has raised $3.5 million in a seed funding round led by pi Ventures, along with participation from Bluehill Capital, SOSV, and a global syndicate of
Share this article
If you liked this article share it with your friends.they will thank you later